Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma

Purpose: This study aimed to compare the swallowing function in patients with human papillomavirus–associated oropharyngeal squamous cell carcinoma treated with de-intensified chemoradiation therapy (6 weeks, 60 Gy) versus those receiving standard-of-care chemoradiation therapy (7 weeks, 70 Gy). Met...

Full description

Bibliographic Details
Main Authors: Greg D. Judy, MD, Rebecca Green, MSW, Shannon L. Aumer, MA, Robert J. Amdur, MD, Xianming Tan, PhD, Nathan Sheets, MD, Mark Weissler, MD, Adam Zanation, MD, Samip Patel, MD, Trevor Hackman, MD, William M. Mendenhall, MD, Bhishamjit S. Chera, MD
Format: Article
Language:English
Published: Elsevier 2018-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109418300381

Similar Items

Similar Items